Protein AF-9 (MLLT3) Peptid
MLLT3
Reaktivität: Säugetier
Wirt: Synthetic
BP, WB, IHC
-
- Target Alle AF9 (MLLT3) Produkte
- AF9 (MLLT3) (Protein AF-9 (MLLT3))
- Protein-Typ
- Synthetic
- Spezies
- Säugetier
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequenz
- ERHILQQIVN LIEETGHFHI TNTTFDFDLC SLDKTTVRKL QSYLETSGTS
- Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of MLLT3 antibody,
Alternative Names: MLLT3 control peptide, MLLT3 antibody Blocking Peptide, Anti-MLLT3 Blocking Peptide, myeloid/lymphoid or mixed-lineage leukemia, trithorax homolog, Drosophila, translocated to, 3 Blocking Peptide, AF9 Blocking Peptide, FLJ2035 Blocking Peptide, YEATS3 Blocking Peptide, MLLT3, MLLT-3, MLLT 3, MLLT-3 Blocking Peptide, MLLT 3 Blocking Peptide - Aufreinigung
- The antibody is affinity purified from rabbit antiserum by affinity chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide is removed by chromatogramphy using non-phosphopeptide corresponding to the phosphorylation site.
-
-
- Applikationshinweise
- Optimal conditions should be determined by the investigator
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handhabung
- Avoid repeated freeze/thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20 °C long term.
-
- Target
- AF9 (MLLT3) (Protein AF-9 (MLLT3))
- Hintergrund
- MLLT3 is a regulator of early erythroid and megakaryocytic cell fate in the human system. Expression of MLLT3 in human CD34+ cells induces acute myeloid, lymphoid, or mixed-lineage leukemia in immunodeficient mice.
- Molekulargewicht
- 37 kDa
-
Sie sind hier:
